Younes Maged, Aquilina Gabriele, Engel Karl-Heinz, Fowler Paul, Frutos Fernandez Maria Jose, Fürst Peter, Gürtler Rainer, Gundert-Remy Ursula, Husøy Trine, Manco Melania, Mennes Wim, Passamonti Sabina, Moldeus Peter, Shah Romina, Waalkens-Berendsen Ine, Wölfle Detlef, Wright Matthew, Barat Baviera José Manuel, Degen Gisela, Leblanc Jean-Charles, Herman Lieve, Civitella Consuelo, Giarola Alessandra, Smeraldi Camilla, Tard Alexandra, Vianello Giorgia, Castle Laurence
EFSA J. 2021 Aug 11;19(8):e06693. doi: 10.2903/j.efsa.2021.6693. eCollection 2021 Aug.
The EFSA Panel on Food Additives and Flavourings (FAF) provides a scientific opinion on the safety of crosslinked polyacrylic acid polymers (carbomer) proposed for use as food additive in solid and liquid food supplements. Carbomer is formed from the monomer, acrylic acid, which is polymerised and crosslinked with allyl pentaerythritol (APE). The polymers are synthesised in ethyl acetate using ■■■■■ as free-radical polymerisation initiator. data showed no evidence for systemic availability or biotransformation of carbomer. Carbomer does not raise a concern regarding genotoxicity. Considering the available data set, the Panel derived an acceptable daily intake (ADI) of 190 mg/kg body weight (bw) per day based on a no observed adverse effect level (NOAEL) of 1,500 mg/kg bw per day from a sub-chronic 13-week study in rat, applying a compound specific uncertainty factor (UF) of 8. At the proposed maximum use levels, the exposure estimates ranged at the mean from 1.1 to 90.2 mg/kg bw per day and at the p95 from 12.5 to 237.4 mg/kg bw per day. At the proposed typical use level, the exposure estimates ranged at the mean from 0.7 to 60.2 mg/kg bw per day and at the p95 from 10.3 to 159.5 mg/kg bw per day. The Panel noted that the maximum proposed use levels would result in exposure estimates close to or above the ADI. The Panel also noted that level of exposure to carbomer from its proposed use is likely to be an overestimation. Taking a conservative approach, the Panel considered that exposure to carbomer would not give rise to a safety concern if the proposed maximum use level for solid food supplements is lowered to the typical use level reported by the applicant.
欧洲食品安全局食品添加剂和调味剂专家委员会(FAF)就拟用作固体和液体食品补充剂中食品添加剂的交联聚丙烯酸聚合物(卡波姆)的安全性提供了科学意见。卡波姆由单体丙烯酸形成,丙烯酸与烯丙基季戊四醇(APE)聚合和交联。这些聚合物在乙酸乙酯中使用■■■■■作为自由基聚合引发剂合成。数据表明没有证据显示卡波姆具有全身可利用性或生物转化。卡波姆不存在遗传毒性方面的问题。考虑到现有数据集,专家委员会根据大鼠为期13周的亚慢性研究中每天1500mg/kg体重的未观察到有害作用水平(NOAEL),应用8的化合物特定不确定系数(UF),得出每日可接受摄入量(ADI)为190mg/kg体重。在拟议的最大使用水平下,暴露估计均值范围为每天1.1至90.2mg/kg体重,p95范围为每天12.5至237.4mg/kg体重。在拟议的典型使用水平下,暴露估计均值范围为每天0.7至60.2mg/kg体重,p95范围为每天10.3至159.5mg/kg体重。专家委员会指出,拟议的最大使用水平将导致暴露估计接近或高于ADI。专家委员会还指出,从其拟议用途来看,对卡波姆的暴露水平可能被高估。采取保守方法,专家委员会认为,如果将固体食品补充剂的拟议最大使用水平降低至申请人报告的典型使用水平,则对卡波姆的暴露不会引起安全问题。